Home LiteratureArticle Details
PMID: 7582508 Published · ppublish English Journal Article

The in vitro pharmacology of ZM 241385, a potent, non-xanthine A2a selective adenosine receptor antagonist.

British journal of pharmacology ·Vol. 115 ·No. 6 ·1995-07-00 ·Pages 1096-102

Poucher SM, Keddie JR, Singh P, Stoggall SM, Caulkett PW, Jones G, Coll MG

Abstract

1. This paper describes the in vitro pharmacology of ZM 241385 (4-(2-[7-amino-2-(2-furyl) [1,2,4]-triazolo[2,3-a][1,3,5]triazin- 5-yl amino]ethyl) phenol), a novel non-xanthine adenosine receptor antagonist with selectivity for the A2a receptor subtype. 2. ZM 241385 had high affinity for A2a receptors. In rat phaeochromocytoma cell membranes, ZM 241385 displaced binding of tritiated 5'-N-ethylcarboxamidoadenosine (NECA) with a pIC50 of 9.52, (95% confidence limits, c.l., 9.02-10.02). In guinea-pig isolated Langendorff hearts, ZM 241385 antagonized vasodilatation of the coronary bed produced by 2-chloroadenosine (2-CADO) and 2-[p-(2-carboxyethyl) phenethylamino]-5'-N-ethylcarboxamidoadenosine (CGS21680) with pA2 values of 8.57 (c.l., 8.45-8.68) and 9.02 (c.l., 8.79-9.24) respectively. 3. ZM 241385 had low potency at A2b receptors and antagonized the relaxant effects of adenosine in the guinea-pig aorta with a pA2 of 7.06, (c.l., 6.92-7.19). 4. ZM 241385 had a low affinity at A1 receptors. In rat cerebral cortex membranes it displaced tritiated R-phenylisopropyladenosine (R-PIA) with a pIC50 of 5.69 (c.l., 5.57-5.81). ZM 241385 antagonized the bradycardic action of 2-CADO in guinea-pig atria with a pA2 of 5.95 (c.l., 5.72-6.18). 5. ZM 241385 had low affinity for A3 receptors. At cloned rat A3 receptors expressed in chinese hamster ovary cells, it displaced iodinated aminobenzyl-5'-N-methylcarboxamido adenosine (AB-MECA) with a pIC50 of 3.82 (c.l., 3.67-4.06). 6. ZM 241385 had no significant additional pharmacological effects on the isolated tissues used in these studies at concentrations three orders of magnitude greater than those which block A2a receptors. At 10 microM it displayed only minor inhibition of the bradycardic effects in guinea-pig atria to some concentrations of carbachol. At 10 microM, ZM 241385 had a small inhibitory effect on relaxant effects of isoprenaline in guinea-pig aortae but no effect on sodium nitrite-induced relaxation. ZM 241385(100 microM) was without effect on phenylephrine-induced tone in guinea-pig aortae.7. ZM 241385 (10 microM) had no inhibitory effect on rat hepatocyte phosphodiesterase types I, II, III and IV but caused a small inhibition of the calcium calmodulin-activated type I enzyme.8. ZM 241385 is the most selective adenosine A2a receptor antagonist yet described and is therefore a useful tool for characterization of responses mediated by A2 adenosine receptors.

MeSH Terms
Adenosine/pharmacology Animals Aorta/drug effects Binding, Competitive Dose-Response Relationship, Drug Guinea Pigs Heart/drug effects In Vitro Techniques PC12 Cells Purinergic P1 Receptor Antagonists Radioligand Assay Rats
Chemicals
Purinergic P1 Receptor Antagonists Adenosine
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Poucher S M
Cardiovascular and Metabolism Department, ZENECA Pharmaceuticals, Mereside, Alderley Park, Macclesfield, Cheshire.
Keddie J R
Singh P
Stoggall S M
Caulkett P W
Jones G
Coll M G
References (32)
32 references, click to expand
  1. PD 115,199: an antagonist ligand for adenosine A2 receptors.
    Naunyn Schmiedebergs Arch Pharmacol. 1987 Jan;335(1):64-9 PMID: 3574493
  2. Binding of the A1-selective adenosine antagonist 8-cyclopentyl-1,3-dipropylxanthine to rat brain membranes.
    Naunyn Schmiedebergs Arch Pharmacol. 1987 Jan;335(1):59-63 PMID: 3574492
  3. [3H]CGS 21680, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain.
    J Pharmacol Exp Ther. 1989 Dec;251(3):888-93 PMID: 2600819
  4. The coexistence of adenosine A1 and A2 receptors in guinea-pig aorta.
    Eur J Pharmacol. 1990 Nov 13;190(3):329-35 PMID: 2272371
  5. 2-Alkoxyadenosines: potent and selective agonists at the coronary artery A2 adenosine receptor.
    J Med Chem. 1991 Apr;34(4):1334-9 PMID: 2016707
  6. L-NG-nitro arginine methyl ester exhibits antinociceptive activity in the mouse.
    Br J Pharmacol. 1991 Jan;102(1):198-202 PMID: 2043923
  7. A2A adenosine receptors from rat striatum and rat pheochromocytoma PC12 cells: characterization with radioligand binding and by activation of adenylate cyclase.
    Mol Pharmacol. 1992 Feb;41(2):352-9 PMID: 1311411
  8. Molecular cloning and characterization of an adenosine receptor: the A3 adenosine receptor.
    Proc Natl Acad Sci U S A. 1992 Aug 15;89(16):7432-6 PMID: 1323836
  9. Relative agonist potencies of C2-substituted analogues of adenosine: evidence for adenosine A2B receptors in the guinea pig aorta.
    Eur J Pharmacol. 1992 Jun 5;216(2):235-42 PMID: 1397010
  10. Multiple cyclic nucleotide phosphodiesterase activities from rat brain.
    Biochemistry. 1971 Jan 19;10(2):311-6 PMID: 4321663
  11. Two distinct adenosine-sensitive sites on adenylate cyclase.
    Proc Natl Acad Sci U S A. 1977 Dec;74(12):5482-6 PMID: 271970
  12. Alkylxanthines: inhibition of adenosine-elicited accumulation of cyclic AMP in brain slices and of brain phosphodiesterase activity.
    Life Sci. 1979 Jun 25;24(26):2475-82 PMID: 225626
  13. Adenosine regulates via two different types of receptors, the accumulation of cyclic AMP in cultured brain cells.
    J Neurochem. 1979 Nov;33(5):999-1005 PMID: 228008
  14. Adenosine-sensitive adenylate cyclase in rat brain homogenates: kinetic characteristics, specificity, topographical, subcellular and cellular distribution.
    Mol Pharmacol. 1979 Nov;16(3):790-804 PMID: 530259
  15. Ligand: a versatile computerized approach for characterization of ligand-binding systems.
    Anal Biochem. 1980 Sep 1;107(1):220-39 PMID: 6254391
  16. Evidence for an A1-adenosine receptor in the guinea-pig atrium.
    Br J Pharmacol. 1983 Jan;78(1):207-12 PMID: 6297647
  17. Insulin and glucagon regulate the activation of two distinct membrane-bound cyclic AMP phosphodiesterases in hepatocytes.
    Biochem J. 1983 Jul 15;214(1):99-110 PMID: 6311178
  18. Adenosine relaxes the aorta by interacting with an A2 receptor and an intracellular site.
    Eur J Pharmacol. 1983 Dec 9;96(1-2):61-9 PMID: 6319159
  19. Interaction of barbiturates with adenosine receptors in rat brain.
    Naunyn Schmiedebergs Arch Pharmacol. 1984 May;326(1):69-74 PMID: 6089000
  20. Adenosine receptors.
    Adv Cyclic Nucleotide Protein Phosphorylation Res. 1985;19:29-46 PMID: 2988302
  21. 2-Chloroadenosine, a permeant for the nucleoside transporter.
    Biochem Pharmacol. 1985 Sep 15;34(18):3237-41 PMID: 4038335
  22. Characterization of the A2 adenosine receptor labeled by [3H]NECA in rat striatal membranes.
    Mol Pharmacol. 1986 Apr;29(4):331-46 PMID: 3010074
  23. Species differences in structure-activity relationships of adenosine agonists and xanthine antagonists at brain A1 adenosine receptors.
    FEBS Lett. 1986 Dec 1;209(1):122-8 PMID: 3803571
  24. Adenosine A3 receptors mediate hypotension in the angiotensin II-supported circulation of the pithed rat.
    Br J Pharmacol. 1993 May;109(1):3-5 PMID: 8495245
  25. 8-(3-Chlorostyryl)caffeine (CSC) is a selective A2-adenosine antagonist in vitro and in vivo.
    FEBS Lett. 1993 May 24;323(1-2):141-4 PMID: 8495727
  26. Adenosine receptor subtypes.
    Trends Pharmacol Sci. 1993 Oct;14(10):360-6 PMID: 8296392
  27. 125I-4-aminobenzyl-5'-N-methylcarboxamidoadenosine, a high affinity radioligand for the rat A3 adenosine receptor.
    Mol Pharmacol. 1994 May;45(5):978-82 PMID: 8190112
  28. Effects of the new A2 adenosine receptor antagonist 8FB-PTP, an 8 substituted pyrazolo-triazolo-pyrimidine, on in vitro functional models.
    Br J Pharmacol. 1994 Jun;112(2):659-65 PMID: 8075885
  29. Characterisation of human adenosine type 1, 2a and 2b receptors expressed in CHO cells.
    Biochem Soc Trans. 1994 May;22(2):195S PMID: 7958258
  30. Some quantitative uses of drug antagonists.
    Br J Pharmacol Chemother. 1959 Mar;14(1):48-58 PMID: 13651579
  31. Biochemical characterization of the triazoloquinazoline, CGS 15943, a novel, non-xanthine adenosine antagonist.
    J Pharmacol Exp Ther. 1987 May;241(2):415-20 PMID: 2883298
  32. Apparent affinity of 1,3-dipropyl-8-cyclopentylxanthine for adenosine A1 and A2 receptors in isolated tissues from guinea-pigs.
    Br J Pharmacol. 1989 Aug;97(4):1274-8 PMID: 2790383
Article Info
Journal
British journal of pharmacology
Abbr.
Br J Pharmacol
ISSN
0007-1188
Published
1995-07-00
Pages
1096-102
Language
English
Region
England
NLM ID
7502536
PMCID
PMC1909020
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]